Lung cancer patients on drug from China’s Akeso lived longer
Patients on ivonescimab lived longer by four months compared to those on immunotherapy.
Original Source
Read the full article at Straitstimes →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.